JeanMarieElwingMD
Pulmonology • Cincinnati, OHCritical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine
Professor, Director Pulmonary Hypertension Program, Pulmonary and Critical Care Medicine, University of Cincinnati College of Medicine
Dr. Elwing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Holmes Hospital, 200 Albert Sabin Way
3rd Floor Pulmonary
Cincinnati, OH 45227Phone+1 513-475-8523Fax+1 513-475-7327
Summary
- Dr. Jean Elwing, based in Cincinnati, Ohio, is a physician specializing in Pulmonology with sub-specialties in Pulmonary Vascular Medicine. She completed her education and residency at Saint Louis University School of Medicine and further pursued a fellowship in Pulmonary Disease and Critical Care Medicine from the University of Cincinnati Medical Center/College of Medicine. Dr. Elwing has experience in the management of conditions such as pulmonary hypertension, pulmonary embolism and chronic right heart failure. She has been involved in multiple clinical trials related to her specialty and has published in several respected journals in her field.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
St Louis University School of MedicineResidency, Internal Medicine/Pediatrics, 1997 - 2001- Saint Louis University School of MedicineClass of 1997
Certifications & Licensure
OH State Medical License 2003 - 2027- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
- Join now to see all
Publications & Presentations
PubMed
- 28 citationsRight ventricular ejection efficiency: a new echocardiographic measure of mechanical performance in chronic pulmonary hypertension.Angel López-Candales, Francisco R. Lopez, Setu Trivedi, Jean Elwing
Echocardiography. 2014-04-01 - 14 citationsPulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension.Arun Jose, Shimul A. Shah, Nadeem Anwar, Courtney R. Jones, Kenneth E. Sherman
Liver Transplantation. 2021-06-29 - 5 citationsSeralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.Robert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald L Zolty
The Lancet. Respiratory Medicine. 2024-07-01
Press Mentions
PHA Recognizes Outstanding Members of the Pulmonary Hypertension CommunitySeptember 3rd, 2024- Advances Made in UC Research Extending LivesOctober 17th, 2022
- Team PHenomenal Hope Sets Out PH Awareness Month ChallengesNovember 2nd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
